Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27 KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

By Shintani S.   Li C.   Mihara M.   Yano J.   Terakado N.   Nakashiro K.-i.   Hamakawa H.  

Oral Oncology, Vol. 40, Iss. 1, 2004-01 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite

T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies

By Garrido Greta   Lorenzano Pablo   Sánchez Belinda   Beausoleil Irene   Alonso Daniel   Pérez Rolando   Fernández Luis  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1701-1710

Springer Publishing Company

Access to resources Recommend Favorite

Epigallocatechin3gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase2

By        

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 1085-1089

Spandidos Publications

Access to resources Recommend Favorite

Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

By                

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 201-207

Spandidos Publications

Access to resources Recommend Favorite

(-)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-κB and AP-1 in endothelial cells

By              

International Journal of Oncology, Vol. 43, Iss. 3, 2013-01 ,pp. : 868-876

Spandidos Publications

Access to resources Recommend Favorite